{"database": "lobbying", "table": "lobbying_activities", "rows": [[782567, "23ad5cb2-7e8e-40f1-b9d5-db3836889ce7", "Q2", "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 1466, "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 2009, "second_quarter", "MED", "AACC wrote to the Agency for Healthcare Research and Quality recommending priority research areas for how the $300 million it received for comparative effectiveness under S.1, the American Recovery and Reinvestment Act of 2009, Title VIII, HHS, AHRQ, Health Research and Quality, should be allocated", "Agency for Healthcare Research & Quality (AHRQ),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", null, 10000, 0, 0, "2009-07-06T15:13:09-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["782567"], "units": {}, "query_ms": 0.45812095049768686, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}